Intermittent Fasting for Pancreatitis
NCT04760847 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2025-04-22
Summary
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.
Conditions
- Pancreatitis
- Pancreatitis, Acute
- Pancreatitis, Chronic
- Pancreas Disease
- Acute Recurrent Pancreatitis
Interventions
- OTHER
-
Intermittent Fasting
These subjects will will then receive information regarding intermittent fasting, which would include fasting for a 16-hour period each day, followed by ingestion of an appropriate number of calories for the remaining part of the day. See attached IF Quick Facts for details provided to the patient.
- OTHER
-
No intermittent fasting
These subjects will undergo standard caloric dietary guidance. Patients in group B will also be given the above information, though not be asked to intermittently fast
Sponsors & Collaborators
-
H. Lee Moffitt Cancer Center and Research Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-31
- Primary Completion
- 2026-04-01
- Completion
- 2026-04-01
Countries
- United States
Study Locations
More Related Trials
-
Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
NCT01954732 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
NCT06253117 ·Status: RECRUITING ·Phase: PHASE2
-
Diet and Exercise After Pancreatic Cancer
NCT03187028 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
NCT00547612 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer
NCT02745197 ·Status: WITHDRAWN ·Phase: PHASE2
-
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07217717 ·Status: RECRUITING ·Phase: PHASE3
-
The North American Pancreatitis Study
NCT01545167 ·Status: COMPLETED
-
Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer
NCT00967291 ·Status: TERMINATED ·Phase: PHASE2
-
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
NCT05980221 ·Status: UNKNOWN ·Phase: NA
-
Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
NCT01419483 ·Status: TERMINATED ·Phase: NA
-
Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center
NCT06712797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PROOF: Pancreatitis-associated Risk Of Organ Failure
NCT03075605 ·Status: COMPLETED
-
Cancer of the Pancreas Screening Study (CAPS 3)
NCT00438906 ·Status: COMPLETED
-
Pancreatic Exocrine Insufficiency in Acute Pancreatitis
NCT02563080 ·Status: COMPLETED
-
Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency
NCT01094600 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
NCT01845467 ·Status: WITHDRAWN
-
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
NCT00068575 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer
NCT02048384 ·Status: COMPLETED ·Phase: PHASE1
-
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
NCT05692596 ·Status: ACTIVE_NOT_RECRUITING
-
R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer
NCT00005843 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer
NCT00897741 ·Status: COMPLETED
-
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT04473794 ·Status: RECRUITING
-
Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas
NCT00038701 ·Status: TERMINATED ·Phase: PHASE2
-
Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy
NCT05480241 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer
NCT04631445 ·Status: COMPLETED ·Phase: NA